Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xian Bi Xin in Acute Ischemic Stroke (TASTE-2)
NCT05249920Phase 3Completed
- Sponsor
- Beijing Tiantan Hospital
- Start
- Mar 2022
- Primary completion
- Feb 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of edaravone dexborneol in ischemic stroke, sponsored by Beijing Tiantan Hospital. Started Mar 2022; status: completed.
02
Drugs
edaravone dexborneol
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT05249920.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05249920.